Glucose Metabolism Modification Induced by Radioligand Therapy with [¹⁷⁷Lu]Lu/[⁹⁰Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial

• Main Authors: Luca Urso (Author), Stefano Panareo (Author), Angelo Castello (Author), Maria Rosaria Ambrosio (Author), Maria Chiara Zatelli (Author), Matteo Caracciolo (Author), Eugenia Tonini (Author), Giorgia Valpiani (Author), Alessandra Boschi (Author), Licia Uccelli (Author), Corrado Cittanti (Author), Mirco Bartolomei (Author)
• Format: Book
• Published: MDPI AG, 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

[¹⁸F]F-FDG (FDG) PET is emerging as a relevant diagnostic and prognostic tool in neuroendocrine neoplasms (NENs), as a simultaneous decrease in [⁶⁸Ga]Ga-DOTA peptides and increase in FDG uptake (the "flip-flop" phenomenon) occurs during the nat...